Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
暂无分享,去创建一个
S. Izumo | R. Kubota | M. Yoshimitsu | S. Soeda | N. Arima | H. Shimeno | T. Kozako | K. Matsushita | M. Akimoto | Y. White